Condensed Statement of Cash Flows (Unaudited) - USD ($)	2 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2021
Cash flows from operating activities:
Net income	$ (724)	$ 5,200,907
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account		(29,425)
Offering costs allocated to warrants		438,287
Change in fair value of warrant liability		(6,755,525)
Changes in operating assets and liabilities:
Prepaid expense		(101,610)
Long term prepaid expenses		(25,489)
Accrued expenses		118,659
Due to related party		86,886
Net cash used in operating activities	(724)	(1,067,310)
Cash Flows from Investing Activities:
Investment of cash in Trust Account		(151,742,500)
Net cash used in investing activities		(151,742,500)
Cash Flows from Financing Activities:
Proceeds from issuance of founder shares	25,000
Proceeds from sale of Units, net of underwriting discount		146,510,000
Proceeds from issuance of Private Placement Warrants		7,057,500
Proceeds from promissory note – related party	114,361	10,800
Repayment of promissory note – related party		(152,251)
Payment of offering costs	(138,637)	(307,641)
Net cash provided by financing activities	724	153,118,408
Net change in cash		308,598
Cash, beginning of period		34
Cash, end of the period		308,632
Supplemental disclosure of cash flow information:
Initial value of Class A common stock subject to possible redemption		$ 151,742,500